Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

PMSA-untargeted cisplatin/irinotecan-loaded nanoparticles

Based on

1 Patents
2014 Most recent source

Composition

1

Alexa 488-labeling PLGA-PEG

Type Complex Compound
Formula
Role raw materials
2

(S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate

irinotecan Camptosa CPT
Type Single Compound
Formula C33H38N4O6
Role loaded material
3

PLA-succinic acid-conjugated cisplatin

polylactic acid-cisplatin PLA-cisplatin
Type Polymer
Formula
Role loaded material

Properties

Applications

Characterization

Biological effects

Biological system Test details Source

Full content is available to subscribers only

To view content please choose from the following:

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • Alexa 488-linked poly(lactic-co-glycolic acid)
  • PLA-succinic acid-conjugated cisplatin
  • (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate
See all (4)
  1. K9077YeZErR7GTXeQRRNHmD6gkc
Product

PMSA-untargeted cisplatin/irinotecan-loaded nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial